Cardiac Prosthetic Devices Market

Industry Outlook

The global cardiac prosthetic devices market to reach US$ 18,523.0 Mn in 2026 growing at compound annual growth rate (CAGR) of 8.8% during the forecast period from 2018 to 2026. Cardiac prosthetic devices are a significant alternative for treating damaged cardiac functioning. With ever-growing burden of cardiovascular diseases, cardiac prosthetics play an important role in the treatment of diseases and assist in returning to normal life. Technological advances in the products, especially in different types of valves available in the market have played a vital role in managing valvular heart diseases such as regurgitation and stenosis in the aorta and mitral valve. More than 5 million people in the United States are diagnosed with heart valve disease each year. Advances in the pacemaker devices have fueled the uptake of these devices globally. The new generation implantable cardioverter defibrillator (ICD) come with dual function, acting as a pacemaker and keeps track of heart rate to prevent sudden cardiac arrest in case of arrhythmias. Growing cases of sudden cardiac deaths (SCD) globally would boost the demand for ICDs during the forecast period. Around 0.18 million to 0.45 million incidents of SCDs occur in U.S. annually. Moreover, growing prevalence of coronary heart diseases, heart attacks, strokes and other cardiovascular ailments worldwide are also assisting the growth of cardiac prosthetic devices market. Around 92.1 million American adults are living with some form of cardiovascular disorder and after-effects of stroke. Cardiovascular diseases and strokes account for US$ 329.7 billion direct and indirect costs associated with the diseases including healthcare costs and lost productivity.

Market Synopsis

Growing Prevalence of Cardiovascular Diseases to Drive the Demand for Cardiac Prosthetic Devices

In 2017, pacemakers held the largest share in the global cardiac prosthetic devices market. Technological advancements in pacemakers such as microprocessor controlled devices and dynamic pacemaker technology are enhancing the device performance and contributing to the market growth. Implantable pacemakers are the leading segment by type of pacemakers due to rising prevalence of cardiac arrhythmia cases, bradycardia, tachycardia etc. External pacemakers serve as a potential market for the management of bradyarrythmia owing to meritorious features such as ergonomic dials design and soft keys to set stimulation parameters. Heart valves would grow at a significant rate during the forecast period owing to rising cases of heart valve diseases, strokes and coronary heart disorder. Growing inclination of minimally invasive surgeries would further drive the market of cardiac heart valves market. Artificial hearts are newer technology in the market and expected to grow at an exponential rate during the forecast period.

North America to lead the Cardiac Prosthetic Devices Market

North America held the largest share in the global cardiac prosthetic devices market owing to high burden of cardiovascular diseases in the region. Strokes and cardiovascular disorders accounted for 14% of overall healthcare expenditure in 2013-2014, more than any other diagnostic group. Moreover, the total direct medical cost of CVD is projected to increase to US$ 749 billion by 2035. High awareness and affordability of cardiac prosthetic devices in the U.S. are also an important factor driving the growth of the market. Asia Pacific emerged as the fastest growing region in the market due to higher target population in the region. Growing healthcare infrastructure and healthcare spending in the region have made Asia Pacific a lucrative market for cardiac prosthetic devices.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Cardiac Prosthetic devices market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on device type and geography.

Market is studied in order to understand the current dynamics and future trends in the global cardiac prosthetic devices market. The study includes market size and forecast for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rate (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The prominent players operating the global cardiac prosthetics market are Medtronic plc, Boston Scientific Corporation, Abbott Vascular, Edwards Lifesciences Corporation, Sorin Group, Biotronik, and SynCardia among others. The companies are engaging in mergers and acquisitions to maintain competency in the market. In 2017, Abbott Laboratories, Inc., acquired St. Jude Medical, Inc. to extend its product offering in cardiovascular treatment solutions. Number of companies are collaborating with Universities for the development of Total Artificial Heart (TAH) solutions.

Key questions answered in this report

• How the global cardiac prosthetic devices market will perform during the forecast period from 2018 to 2026?
• What are the latest trends in the cardiac prosthetic devices market and valuable opportunities for key players?
• Who are the leading players in the global cardiac prosthetic devices market?
• Which is the leading/and fastest region in the global cardiac prosthetic devices market?
• Currently, what are the regulatory structure for the cardiac prosthetic devices?
• What are drivers and restrains governing the global cardiac prosthetic devices market?
• What is epidemiology of cardiovascular diseases globally?
• What is the future of cardiac prosthetic devices and how it will shape the cardiovascular disease management

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global CPD Market Portraiture
2.2. Global CPD Market, by Device Type, 2017 (US$ Mn)
2.3. Global CPD Market, by Geography, 2017 (US$ Mn)

Chapter 3. Cardiac Prosthetic Devices (CPD) Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global CPD Market, by Key Players, 2017

Chapter 4. Global Cardiac Prosthetic Devices (CPD) Market, by Device Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Heart Valve
4.2.1. Mechanical Heart Valve
4.2.2. Tissue Heart Valve
4.2.3. Transcatheter Heart Valves
4.3. Pacemakers
4.3.1. Implantable Pacemakers
4.3.2. External Pacemakers
4.4. Artificial Heart

Chapter 5. Global Cardiac Prosthetic Devices (CPD) Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. North America CPD Market Analysis, 2016 – 2026
5.1.1. North America CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
5.1.2. North America CPD Market, by Country, 2016 – 2026 (US$ Mn)
5.1.2.1. U.S.
5.1.2.2. Canada
5.2. Europe CPD Market Analysis, 2016 – 2026
5.2.1. Europe CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
5.2.2. Europe CPD Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.2.2.1. U.K.
5.2.2.2. Germany
5.2.2.3. Rest of Europe
5.3. Asia Pacific CPD Market Analysis, 2016 – 2026
5.3.1. Asia Pacific CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
5.3.2. Asia Pacific CPD Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. China
5.3.2.2. Japan
5.3.2.3. Rest of Asia Pacific
5.4. Latin America CPD Market Analysis, 2016 – 2026
5.4.1. Latin America CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
5.4.2. Latin America CPD Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. Brazil
5.4.2.2. Mexico
5.4.2.3. Rest of Latin America
5.5. Middle East & Africa CPD Market, 2016 – 2026
5.5.1. Middle East & Africa CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
5.5.2. Middle East & Africa CPD Market, by Region, 2016 – 2026 (US$ Mn)
5.5.2.1. GCC
5.5.2.2. Rest of Middle East & Africa

Chapter 6. Company Profiles
6.1. Medtronic PLC
6.1.1. Business Description
6.1.2. Financial Information (Subject to Data Availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Boston Scientific Corporation
6.3. Edwards Lifesciences Corporation
6.4. Abbott Vascular (Abbott Laboratories, Inc.)
6.5. Sorin Group
6.6. Biotronik
6.7. CryoLife, Inc.
6.8. Lepu Medical Technology Co. Ltd.
6.9. Meril Life Sciences Pvt. Ltd.
6.10. Abiomed, Inc.
6.11. SynCardia Systems, LLC
6.12. Carmat

List of Figures

FIG 1. Cardiac Prosthetic Devices (CPD) Market: Research Methodology
FIG 2. CPD Market Segmentation
FIG 3. Global CPD Market, by Device Type, 2017 (US$ Mn)
FIG 4. Global CPD Market, by Geography, 2017 (US$ Mn)
FIG 5. Attractive Investment Proposition, by Geography, 2017
FIG 6. Competitive Analysis: Global CPD Market, by Key Players, 2017
FIG 7. Global Mechanical Heart Valve Market in Cardiac Prosthetic Devices, 2016-2026 (US$ Mn)
FIG 8. Global Tissue Heart Valve Market in Cardiac Prosthetic Devices, 2016-2026(US$ Mn)
FIG 9. Global Transcatheter Heart Valve Market in Cardiac Prosthetic Devices, 2016-2026(US$ Mn)
FIG 10. Global Implantable Pacemakers Market in Cardiac Prosthetic Devices, 2016-2026(US$ Mn)
FIG 11. Global External Pacemakers Market in Cardiac Prosthetic Devices, 2016-2026(US$ Mn)
FIG 12. Global Artificial Heart Market in Cardiac Prosthetic Devices, 2016-2026(US$ Mn)
FIG 13. U.S. CPD Market, 2016-2026 (US$ Mn)
FIG 14. Canada CPD Market, 2016-2026 (US$ Mn)
FIG 15. U.K. CPD Market, 2016-2026 (US$ Mn)
FIG 16. Germany CPD Market, 2016-2026 (US$ Mn)
FIG 17. Rest of Europe CPD Market, 2016-2026 (US$ Mn)
FIG 18. China CPD Market, 2016-2026 (US$ Mn)
FIG 19. Japan CPD Market, 2016-2026 (US$ Mn)
FIG 20. Rest of Asia Pacific CPD Market, 2016-2026 (US$ Mn)
FIG 21. Brazil CPD Market, 2016-2026 (US$ Mn)
FIG 22. Mexico CPD Market, 2016-2026 (US$ Mn)
FIG 23. Rest of Latin America CPD Market, 2016-2026 (US$ Mn)
FIG 24. GCC CPD Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Middle East & Africa CPD Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Cardiac Prosthetic Devices (CPD) Market Portraiture
TABLE 2 Global CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global CPD Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 North America CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
TABLE 5 North America CPD Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 Europe CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
TABLE 7 Europe CPD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 Asia Pacific CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific CPD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Latin America CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America CPD Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Middle East & Africa CPD Market, by Device Type, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East & Africa CPD Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14 Medtronic PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Edwards Lifesciences Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Abbott Vascular (Abbott Laboratories, Inc.): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Sorin Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Biotronik: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Lepu Medical Technology Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Meril Life Sciences Pvt. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Abiomed, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 SynCardia Systems, LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Carmat: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)